CIDP (chronic inflammatory demyelinating polyneuropathy): open trials in Canada

• NCT05327114

  Efficacy and Safety Study of Nipocalimab for Adults With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

  Trial Treatment · Phase 2/3 · Janssen Research & Development, LLC

  The Ottawa Hospital Ottawa NeuroMuscular Centre, Ottawa

  Registry updated 2026-11-03

• NCT06920004

  A Study to Assess Efficacy and Safety of Empasiprubart Versus IVIg in Adults With CIDP

  Trial Treatment · Phase 3 · argenx

  University Of Calgary, Calgary · University of Alberta, Edmonton · Black Tusk Research Group, Vancouver

  Registry updated 2026-11-03

• NCT06859099

  Long-term Safety and Efficacy Study of Riliprubart in Participants With CIDP

  Trial Treatment · Phase 3 · Sanofi

  Investigational Site Number : 1240001, Gatineau · Investigational Site Number : 1240002, Québec

  Registry updated 2026-10-27

• NCT06290141

  A Study to Test the Efficacy and Safety of Riliprubart Against the Usual Treatment of Intravenous Immunoglobulin (IVIg) in People With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

  Trial Treatment · Phase 3 · Sanofi

  Investigational Site Number : 1240003, London · Investigational Site Number : 1240006, Montreal · Investigational Site Number : 1240001, Québec · Investigational Site Number : 1240002, Toronto

  Registry updated 2026-10-19

• NCT07304154

  Study of KITE-363 in Participants With Autoimmune Neurologic Diseases That Did Not Respond to Usual Treatment

  Trial Treatment · Phase 1 · Kite, A Gilead Company

  Centre Intégré Universitaire de Sante et Services Sociaux de L'Est de I'lle de Montreal / installation Hopital Maisonneuve-Rosemont, Montreal · Jewish General Hospital, Montreal · The Ottawa Hospital - General Campus, Ottawa

  Registry updated 2026-10-19

All CIDP (chronic inflammatory demyelinating polyneuropathy) trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error